Our research group is working on over 50 projects, not only involving Hyaluronic Acid, through the constant dialogue between different functions: discovery, formulation development, pre-clinical and clinical research, pharmacovigilance, regulatory affairs and marketing.
We have implemented numerous pre-clinical and clinical studies in collaboration with prestigious international centres for research.
Our scientific approach leads us to also treat medical devices as though they were drugs – we have been pioneers in this and today all regulatory bodies are also moving in this direction.
We have a large portfolio of patents worldwide – about 1.400 – of which more than 1.200 related to Hyaluronic Acid with different molecular weights, industrial processes, pharmaceutical formulations, compositions and applications.
![](https://www.fidiapharma.ae/wp-content/uploads/2021/10/Per-innovare-ed-evolvere.jpg)
Our commitment to research and development means we can add every day new solutions to our therapeutic areas.
![](https://www.fidiapharma.ae/wp-content/uploads/2022/04/Fidia_Noto_RD.jpg)
Our partners
We collaborate with leading research centres in Europe and in the US and top Italian universities.